Terminated NA INTERVENTIONAL 2-arm NCT02027272

Eclampsia and Posterior Reversible Encephalopathy Syndrome (PRES): (PRESIDEX)

Eclampsia and Posterior Reversible Encephalopathy Syndrome (PRES): A Randomized Clinical Trial Evaluating Corticosteroid Efficacy to Augment Standard Therapy and Shorten Recovery.

Sponsor: University of Mississippi Medical Center

Conditions Eclampsia

Interventions Dexamethasone

Updated 7 times since 2017 Last updated: Apr 19, 2016 Started: Feb 29, 2012 Primary completion: Dec 31, 2013 Completion: Dec 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Difficulty recruiting, only one participant in 18 months, rarity of event

Other terminated trials from University of Mississippi Medical Center

See all terminations from University of Mississippi Medical Center

A NA clinical study on Eclampsia, this trial is terminated or withdrawn. The trial is conducted by University of Mississippi Medical Center and has accumulated 7 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jan 2023 — Jul 2024 [monthly]

Terminated NA
Dec 2022 — Jan 2023 [monthly]

Terminated NA
Jan 2021 — Dec 2022 [monthly]

Terminated NA

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Terminated NA
Jan 2017 — Jun 2018 [monthly]

Terminated NA

First recorded

Feb 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Mississippi Medical Center

Data source: University of Mississippi Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Jackson, United States